CAMERON REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
CAMERON REGIONAL MEDICAL CENTER is a 42-bed rural/critical access in CLINTON, MO with $65.0M in net patient revenue and a -12.0% operating margin. The hospital serves a payer mix of 50.4% Medicare, 7.0% Medicaid, and 42.6% commercial.
Thesis: Turnaround. Our ML models identify $4.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.0% to -4.6% (+736bps).
| Net Revenue HCRIS | $65.0M |
| Current EBITDA COMPUTED | $-7.8M |
| Operating Margin COMPUTED | -12.0% |
| Occupancy HCRIS | 42.0% |
| Revenue / Bed COMPUTED | $1.5M |
| Net-to-Gross HCRIS | 33.3% |
| Distress Probability ML | 51.3% |
2. Market Context & Competitive Position
MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -12.0% places it below the state median. Among 65 size-comparable peers (21-84 beds), the median margin is -9.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (21-84), prioritizing same-state peers. 65 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CAMERON REGIONAL MEDICAL CENTE (Target) | MO | 42 | $65.0M | -12.0% |
| BARNES JEWISH WEST COUNTY HOSP | MO | 68 | $221.1M | 4.9% |
| CITIZENS MEMORIAL HOSPITAL DIS | MO | 52 | $178.3M | -19.3% |
| LEES SUMMIT MEDICAL CENTER | MO | 80 | $146.7M | 13.6% |
| GOLDEN VALLEY MEMORIAL HOSPITA | MO | 42 | $139.8M | -4.9% |
| PROGRESS WEST HOSPITAL | MO | 69 | $112.0M | 11.7% |
| WESTERN MISSOURI MEDICAL CENTE | MO | 45 | $108.5M | -9.2% |
| MERCY HOSPITAL LEBANON | MO | 43 | $94.1M | 15.5% |
| BELTON REGIONAL MEDICAL CENTER | MO | 62 | $92.1M | 17.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $791K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $42K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-7.8M |
| + RCM Uplift | +$4.8M |
| Pro Forma EBITDA | $-3.0M |
| Current Margin | -12.0% |
| Pro Forma Margin | -4.6% |
| WC Released (1x) | $2.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-12.0M | $-3.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-12.0M | $-7.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-10.8M | $4.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-10.8M | $1.3M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-13.2M | $-23.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-13.2M | $-30.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 51.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 65 hospitals with 21-84 beds
- Same-state prioritization (n=66)
- Comp margins: P25=-16.3% / P50=-9.2% / P75=4.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.